References
Monticone S, Losano I, Tetti M, Buffolo F, Veglio F, Mulatero P (2018) Diagnostic approach to low-renin hypertension. Clin Endocrinol 89:385–396
Simonetti GD, Mohaupt MG, Bianchetti MG (2012) Monogenic forms of hypertension. Eur J Pediatr 171:1433–1439
Disse-Nicodème S, Achard JM, Potier J, Delahousse M, Fiquet-Kempf B, Stern N, Blanchard A, Guilbaud JC, Niaudet P, Chauveau D, Dussol B, Berland Y, Dequiedt P, Ader JL, Paillard M, Grünfeld JP, Fournier A, Corvol P, Jeunemaitre X (2001) Familial hyperkalemic hypertension (Gordon syndrome): evidence for phenotypic variability in a study of 7 families. Adv Nephrol Necker Hosp 31:55–68
Gordon RD (1986) Syndrome of hypertension and hyperkalemia with normal glomerular filtration rate. Hypertension 8:93–102
Ellison DH (1993) Pseudohypoaldosteronism type II. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A (eds) GeneReviews((R)). University of Washington, Seattle
Mulatero P, Verhovez A, Morello F, Veglio F (2007) Diagnosis and treatment of low-renin hypertension. Clin Endocrinol 67:324–334
Yang CL, Angell J, Mitchell R, Ellison DH (2003) WNK kinases regulate thiazide-sensitive Na-Cl cotransport. J Clin Invest 111:1039–1045
Boyden LM, Choi M, Choate KA, Nelson-Williams CJ, Farhi A, Toka HR, Tikhonova IR, Bjornson R, Mane SM, Colussi G, Lebel M, Gordon RD, Semmekrot BA, Poujol A, Välimäki MJ, De Ferrari ME, Sanjad SA, Gutkin M, Karet FE, Tucci JR, Stockigt JR, Keppler-Noreuil KM, Porter CC, Anand SK, Whiteford ML, Davis ID, Dewar SB, Bettinelli A, Fadrowski JJ, Belsha CW, Hunley TE, Nelson RD, Trachtman H, Cole TR, Pinsk M, Bockenhauer D, Shenoy M, Vaidyanathan P, Foreman JW, Rasoulpour M, Thameem F, Al-Shahrouri HZ, Radhakrishnan J, Gharavi AG, Goilav B, Lifton RP (2012) Mutations in kelch-like 3 and cullin 3 cause hypertension and electrolyte abnormalities. Nature 482:98–102
O'Shaughnessy KM (2015) Gordon syndrome: a continuing story. Pediatr Nephrol 30:1903–1908
Mayan H, Munter G, Shaharabany M, Mouallem M, Pauzner R, Holtzman EJ, Farfel Z (2004) Hypercalciuria in familial hyperkalemia and hypertension accompanies hyperkalemia and precedes hypertension: description of a large family with the Q565E WNK4 mutation. J Clin Endocrinol Metab 89:4025–4030
Osawa M, Ogura Y, Isobe K, Uchida S, Nonoyama S, Kawaguchi H (2013) Cul3 gene analysis enables early intervention for pediatric pseudohypoaldosteronism type II in infancy. Pediatr Nephrol 28:1881–1884
Tsuji S, Yamashita M, Unishi G, Takewa R, Kimata T, Isobe K, Chiga M, Uchida S, Kaneko K (2013) A young child with pseudohypoaldosteronism type II by a mutation of cullin 3. BMC Nephrol 14:166
Brüngger M, Hulter HN, Krapf R (1997) Effect of chronic metabolic acidosis on the growth hormone/IGF-1 endocrine axis: new cause of growth hormone insensitivity in humans. Kidney Int 51:216–221
Goldberg R, Reshef-Bankai E, Coleman R, Green J, Maor G (2006) Chronic acidosis-induced growth retardation is mediated by proton-induced expression of Gs protein. J Bone Miner Res 21:703–713
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that there is no conflict of interest.
Patient confidentiality
The patient’s parents provided informed consent for publication of the submitted article and the results of the accompanying genetic analyses.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This refers to the article that can be found at https://doi.org/10.1007/s00467-019-04351-2.
Rights and permissions
About this article
Cite this article
Yavas Abali, Z., Yesil, G., Kirkgoz, T. et al. Rare cause of severe hypertension in an adolescent boy presenting with short stature: Answers. Pediatr Nephrol 35, 405–407 (2020). https://doi.org/10.1007/s00467-019-04352-1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00467-019-04352-1